Paper Details

  1. Home
  2. Paper Details

Who should receive recombinant human erythropoietin?

Author: Van StoneJ C

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Recombinant human erythropoietin (r-HuEPO) is effective in treating severe anemia related to end-stage renal disease. The goal of r-HuEPO therapy is to maintain the hematocrit level at 35%. Possible side effects include hypertension, seizures, myalgia, malaise, headache, gastrointestinal distress, and injected conjunctiva. The major benefits of r-HuEPO therapy are reduced need for transfusion and marked improvement in quality-of-life parameters.
Paper Details　
Original Abstract of the Article :
The treatment of severe anemia related to end-stage renal disease with recombinant human erythropoietin (r-HuEPO; EPOGEN, [epoetin alfa] AMGEN Inc, Thousand Oaks, CA) has been investigated in more than 1,500 hemodialysis patients worldwide. The goal of r-HuEPO therapy is to maintain the hematocrit l...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2669084

データ提供：米国国立医学図書館（NLM）

Recombinant Human Erythropoietin: A Life-Giving Oasis in the Desert of Anemia

Anemia, a condition characterized by a low red blood cell count, can be a grueling desert trek for those suffering from end-stage renal disease. This research explores the use of recombinant human erythropoietin (r-HuEPO) as a potential oasis in the desert of anemia management. The researchers investigated the effectiveness of r-HuEPO in treating severe anemia related to end-stage renal disease and analyzed its potential benefits and risks.

r-HuEPO: A Life-Giving Oasis for Anemia

The study showed that r-HuEPO was effective in increasing red blood cell production and improving hematocrit levels in patients with end-stage renal disease. This is like finding a life-giving oasis in the desert, offering a way to combat the debilitating effects of anemia. The study also highlighted the importance of careful monitoring of blood pressure, iron status, and potential side effects, such as hypertension and seizures.

Navigating the Desert of Renal Disease: Personalized Care and Monitoring

This research underscores the potential benefits of r-HuEPO in managing anemia associated with end-stage renal disease. It also emphasizes the need for personalized care and close monitoring to ensure the safe and effective use of this treatment. The desert of renal disease can be challenging, but with careful management and the right resources, patients can find oases of hope and improve their overall quality of life.

Dr. Camel's Conclusion

This research offers a promising oasis in the desert of anemia management, highlighting the potential benefits of r-HuEPO for those battling end-stage renal disease. However, the research also stresses the importance of careful monitoring and individualized care to ensure the safe and effective use of this treatment. Just as a desert traveler needs to carefully navigate the landscape to find and utilize resources, patients with renal disease must work closely with their healthcare team to ensure a successful journey towards better health.

Date :
  1. Date Completed 1989-09-19
  2. Date Revised 2007-11-15
Further Info :

Pubmed ID

2669084

DOI: Digital Object Identifier

2669084

Related Literature

Article Analysis
・Side Effects of epoetin alfa injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.